Structured Medical Weight Loss offers advanced metabolic programs tailored to provide measurable and sustainable fat loss through clinical precision and ongoing provider oversight
A large observational study published in Diabetologia in 2022 looked at GLP-1 receptor agonist use in humans and found no statistically significant increase in thyroid cancer risk
On May 1, 2026, the department authorized a second generic semaglutide injection, filed by Canadian-based Apotex, and said it was reviewing seven other submissions for generic semaglutide by different companies
The microbiome data emerging alongside retatrutide and MASLD: Interpreting Liver-Fat Reductions and Microbiome Signals From Emerging GLP-3 Data are the most scientifically provocative element of recent readouts
Place Ozempic and any medical accessories, such as cooling packs, in a clear plastic bag for security screening
519 While early models have shown promising results, the application of GLP-1RAs in cancer treatment has not yet been established and requires further clinical trials